IMMUNITOR
Since 2000, Immunitor has been developing orally-delivered immunotherapies for a number of serious diseases affecting the world. Immunitor products are used as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, tuberculosis, broad-spectrum bacterial and fungal infections, cancer; and atherosclerosis/obesity. Immunitor Inc. is the global holding corporation for Immunitor product and manufacturing rights and assets. Currently, Immunitor has GMP manufacturing capability in Thailand. Specific Immunitor products are registered in several Asian and African countries. Immunitor CEO is Dr. Aldar S. Bourinbaiar, the manufacturing plant is run by Mr. Vichai Jirathitikal. These two individuals are the respective main shareholders of the company.
IMMUNITOR
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2000-01-01
Address:
Chachoengsao, Chachoengsao, Thailand
Country:
Thailand
Website Url:
http://www.immunitor.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF Apache PHP DigiCert SSL CentOS Apache 2.2 RapidSSL Thickbox
Current Employees Featured
Founder
Official Site Inspections
http://www.immunitor.com Semrush global rank: 5.31 M Semrush visits lastest month: 1.56 K
- Host name: server.smartcow.org
- IP address: 68.169.51.186
- Location: Norcross United States
- Latitude: 33.9733
- Longitude: -84.2231
- Metro Code: 524
- Timezone: America/New_York
- Postal: 30092
More informations about "Immunitor"
Immunitor - Oral Vaccines
Immunitor Inc. is the global holding corporation for Immunitor product and manufacturing rights and assets. Currently, Immunitor has GMP manufacturing capability in Thailand. Specific …See details»
Immunitor - Crunchbase Company Profile & Funding
Immunitor products are used as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, tuberculosis, broad-spectrum bacterial and fungal infections, …See details»
Immunitor Company Profile 2024: Valuation, Investors ... - PitchBook
Immunitor General Information Description. Manufacturer and developer of immunotherapies and therapeutic vaccines intended for the treatment of tuberculosis. The company is engaged in …See details»
IMMUNITOR Ltd. Overview | SignalHire Company Profile
IMMUNITOR Ltd. is a private company that has been in the industry for 23 years. The company currently specializes in the Biotechnology, Pharmaceuticals areas. ... Organization Website: …See details»
Immunitor Company Profile | Management and Employees List
Immunitor Profile and History Since 2000 Immunitor has been developing orally-delivered immunotherapies for a number of serious diseases affecting the world. Immunitor products are …See details»
Immunitor - Overview, News & Similar companies | ZoomInfo.com
Feb 1, 2020 Immunitor products are used as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, tuberculosis, broad spectrum bacterial and fungal …See details»
Immunitor - Products, Competitors, Financials, Employees, …
Immunitor focuses on the development of orally-delivered immunotherapies within the pharmaceutical industry. Use the CB Insights Platform to explore Immunitor's full profile. …See details»
Organization | Immunitor LLC - Purdue University
Organization Overview. First Clinical Trial. 2010 NCT01222338. First Marketed Drug. None First NDA Approval. None ... Immunitor Inc. | Immunitor LLC | Immunitor USA Inc. Active …See details»
Immunitor - Oral Vaccines
For more information please email [email protected]. Home | About | Products | Science | Publications | News | Contact © Copyright 2000-2019. Immunitor, Inc. All ...See details»
Immunitor Inc. | Vancouver, BC, Canada Startup - Gust
Immunitor is a global oral vaccine corporation. For two decades, many successful clinical trials are published in peer-reviewed journals. The most recent Hepko-V5 (hepcortespenlisimut-L, for …See details»
Immunitor, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Sign Up for Free. Last update 01 Nov 2024See details»
Immunitor - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 Organization. Immunitor . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 1. Monthly …See details»
Articles about Immunitor - BioSpace
12 articles about Immunitor. Key Capital HAP-V+ Immune Supplement Reported Effective Against COVID-19, and Colds and Flu. 4/26/2021. KEY CAPITAL CORPORATION advises that …See details»
Immunitor - Contacts, Employees, Board Members, Advisors
Organization. Immunitor . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. Immunitor has 2 current …See details»
Immunitor, Inc. (Immunitor, Inc.) - 药物管线_专利_临床试验_投融营 …
Immunitor: Immunitor, Key Capital's Licensor and Partner is well recognized globally as a pioneer in oral vaccines development. Immunitor has been researching and developing oral pill …See details»
Immunitor - Oral Vaccines
Latest media reports are found here.. Home | About | Products | Science | Publications | News | Contact © Copyright 2000-2019. Immunitor, Inc. All rights reserved.See details»
Key Capital to Fast-track Breakthrough Liver Cancer Immunotherapy
Dec 1, 2020 FDA Orphan Drug Designated Immunitor V5 Development to be AcceleratedNEW YORK, NY / ACCESSWIRE / December 1, 2020 / KEY CAPITAL CORPORATION (OTC …See details»
Immunitor - Oral Vaccines
In contrast, Immunitor is the only company to have successfully developed an oral vaccine available as a simple pill. Mucosal Immunity Almost all infectious agents (viruses, bacteria, …See details»
Immunitor - Oral Vaccines
Immunitor has developed and currently manufactures seven products as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, cancer, …See details»